{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:04:10Z","timestamp":1754157850339,"version":"3.41.2"},"reference-count":48,"publisher":"Emerald","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.emerald.com\/insight\/site-policies"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,12,1]]},"abstract":"<jats:p>A technological community framework can be used to explain and manage new medical technologies. It describes emergence, commercialization, and standardization of an innovation or technology within the context of its whole network (or community) of stakeholders. This framework is used to illustrate the emergence, commercialization, and standardization of a relatively new medical technology \u2013 umbilical cord blood (UCB) banking. Umbilical cord blood may prove to be a source of stem cells for bone marrow transplant that is safer, more accessible, and less expensive than current sources of stem cells. The technological community framework can signal potential problems as the technology emerges, and help healthcare delivery systems and providers to effectively assess and manage the technology. The framework can also be applied to other medical technologies and innovations.<\/jats:p>","DOI":"10.1108\/14777260310698748","type":"journal-article","created":{"date-parts":[[2007,4,13]],"date-time":"2007-04-13T09:41:16Z","timestamp":1176457276000},"page":"399-421","source":"Crossref","is-referenced-by-count":6,"title":["Using a technological community framework to manage new medical technologies"],"prefix":"10.1108","volume":"17","author":[{"given":"C.A.","family":"Rusinko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Sesok\u2010Pizzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"140","reference":[{"key":"key2021010505160665800_b1","unstructured":"Abrams and Hessel (1987), \u201cHealth technology assessment: problems and challenges\u201d, American Journal of Roentgenology, Vol. 149, pp. 1127\u201032."},{"key":"key2021010505160665800_b2","unstructured":"Aekerlof, G.A. (1970), \u201cThe market for lemons: quality, uncertainty and the market mechanism\u201d, Quarterly Journal of Economics, Vol. 84, pp. 488\u2010500."},{"key":"key2021010505160665800_b3","unstructured":"Arcese, W., Iori, A.P., Screnci, M., Guglielmi, C., Mengarelli, A., Carmini, D., Testi, A.M., Moleti, M.L., Cimino, G., Perrone, P., Laurenti, L., Elia, L., Boecklin, F., Romano, A., De Felice, L. and Mandelli, F. (1998), \u201cUmbilical cord blood transplant from HLA\u2010mismatched unrelated donor in high\u2010risk leukemia\u201d, Bone Marrow Transplant, Vol. 21 No. Suppl. 3, pp. S85\u20106."},{"key":"key2021010505160665800_b4","unstructured":"Armitage, S., Warwick, R., Fehily, D., Navarrete, C. and Contreras, M. (1999), \u201cCord blood banking in London: the first 1000 collections\u201d, Bone Marrow Transplant, Vol. 24 No. 2, pp. 139\u201045."},{"key":"key2021010505160665800_b5","doi-asserted-by":"crossref","unstructured":"Barker, J.N., Weisdorf, D.J. and Wagner, J.E. (2001), \u201cCreation of a double chimera after the transplantation of umbilical\u2010cord blood from two partially matched unrelated donors\u201d, New England Journal of Medicine, Vol. 344 No. 24, pp. 1870\u20101.","DOI":"10.1056\/NEJM200106143442417"},{"key":"key2021010505160665800_b8","unstructured":"Broxmeyer, H.E., Srour, E.F., Hangoc, G., Cooper, S., Anderson, S.A. and Bodine, D.M. (2003), \u201cHigh\u2010efficiency recovery of functional hematopoietic progenitor as stem cells from human cord blood cryopreserved for 15 years\u201d, Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, pp. 645\u201050."},{"key":"key2021010505160665800_b7","unstructured":"Broxmeyer, H.E., Douglas, G.W., Hangoc, G., Cooper, S., Bard, J., English, D., Arny, M., Thomas, L. and Boyse, E.A. (1989), \u201cHuman umbilical cord blood as a potential source transplantable haematopoietic stem progenitor cells\u201d, Proceedings of the National Academy of Science of the United States of America, Vol. 86 No. 10, pp. 3828\u201032."},{"key":"key2021010505160665800_b9","unstructured":"Butler, D. (1996), \u201cUS company comes under fire over patent on umbilical cord cells\u201d, Nature, Vol. 382, p. 99."},{"key":"key2021010505160665800_b10","unstructured":"Code of Federal Regulations (CFR) (2003), Vol. 68 No. 13, January 21, Part 1271, pp. 2689\u201091, available at: wais.access.gpo.gov. DOCID: fr21ja03\u20106."},{"key":"key2021010505160665800_b11","unstructured":"Cohen, S. (1996), \u201cTangled lifeline\u201d, The Washington Post Magazine, August 18, pp. 10\u201032."},{"key":"key2021010505160665800_b12","unstructured":"Constant, E.W. (1980), The Origins of the Turbojet Revolution, The Johns Hopkins University Press, Baltimore, MD."},{"key":"key2021010505160665800_b13","unstructured":"Constant, E.W. (1987), \u201cThe social locus of technology practice?\u201d, in Bijker, W.E. et al. (Eds), The Social Construction of Technological Systems, MIT Press, Cambridge, MA."},{"key":"key2021010505160665800_b15","unstructured":"Debackere, K., Clarysse, B., Wijnberg, N.M. and Rappa, M.A. (1994), \u201cScience and industry: a theory of networks and paradigms\u201d, Technology Analysis and Strategic Management, Vol. 6, pp. 21\u201037."},{"key":"key2021010505160665800_b16","unstructured":"Fernandez, M.N. (1998), \u201cEurocord position on ethical and legal issues involved in cord blood transplantation\u201d, Bone Marrow Transplant, Vol. 22, pp. S84\u20105."},{"key":"key2021010505160665800_b17","unstructured":"Garber, S., Ridgely, S.M., Taylor, R.S. and Melli, R. (2000), Managed Care and the Evaluation and Adoption of Emerging Medical Technologies, MR\u20101195\u2010HIMA, RAND, Santa Monica, CA."},{"key":"key2021010505160665800_b18","unstructured":"Garud, R. and Van de Ven, A.H. (1989), \u201cTechnological innovation and industry emergence: the case of cochlear implants\u201d, in Van de Ven, A.H., Angle, H. and Poole, M.S. (Eds), Research on the Management of Innovations, Harper\u2010Collins, New York, NY."},{"key":"key2021010505160665800_b20","unstructured":"Gluckman, E. (2000), \u201cCurrent status of umbilical cord blood hematopoietic stem cell transplantation\u201d, Experimental Hematology, Vol. 28, pp. 1197\u2010205."},{"key":"key2021010505160665800_b22","unstructured":"Gluckman, E., Rocha, V. and Chastang, C. (1998), \u201cCord blood banking and transplant in Europe Eurocord\u201d, Vox Sanguinis, Vol. 74 Suppl 2, pp. 95\u2010101."},{"key":"key2021010505160665800_b23","unstructured":"Gluckman, E., Rocha, V. and Chevret, S. (2001), \u201cResults of unrelated umbilical cord blood hematopoietic stem cell transplant\u201d, Transfusion Clinique et Biologique, Vol. 8 No. 3, pp. 146\u201054."},{"key":"key2021010505160665800_b21","doi-asserted-by":"crossref","unstructured":"Gluckman, E., Rocha, V., Boyer\u2010Chammard, A., Locatelli, F., Arcese, W., Pasquini, R., Ortega, J., Souillet, G., Ferreira, E., Laporte, J.P., Fernandez, M. and Chastang, C. (1997), \u201cOutcome of cord\u2010blood transplantation from related and unrelated donors\u201d, New England Journal of Medicine, Vol. 337, pp. 373\u201081 (report carried out for the for the Eurocord Transplant Group and the European Blood and Marrow Transplantation Group).","DOI":"10.1056\/NEJM199708073370602"},{"key":"key2021010505160665800_b19","doi-asserted-by":"crossref","unstructured":"Gluckman, E., Broxmeyer, H.A., Auerbach, A.D., Friedman, H.S., Douglas, G.W., Devergie, A., Esperou, H., Thierry, D., Socie, G., Lehn, P., Cooper, S., English, D., Kurtzberg, J., Bard, J. and Boyse, E.A. (1989), \u201cHematopoietic reconsitition in a patient with Fanconi's anemia by means of umbilical cord\u2010blood from an HLA\u2010identical sibling\u201d, New England Journal of Medicine, Vol. 321 No. 21, pp. 1174\u20108.","DOI":"10.1056\/NEJM198910263211707"},{"key":"key2021010505160665800_b24","doi-asserted-by":"crossref","unstructured":"Johnson, F.L. (1997), \u201cPlacental blood transplantation and autologous banking: caveat emptor\u201d, Journal of Pediatric Hematology Oncology, Vol. 19, pp. 183\u20106.","DOI":"10.1097\/00043426-199705000-00001"},{"key":"key2021010505160665800_b25","doi-asserted-by":"crossref","unstructured":"Kline, R.M. and Bertolone, S.J. (1998), \u201cUmbilical cord blood transplantation: providing a donor for everyone needing a bone marrow transplant?\u201d, Southern Medical Journal, Vol. 91 No. 9, pp. 821\u20108.","DOI":"10.1097\/00007611-199809000-00004"},{"key":"key2021010505160665800_b26","unstructured":"Laughlin, M.J., Barker, J., Bambach, B., Koc, O.N., Rizzieri, D.A., Wagner, J.E., Gerson, S.L., Lazarus, H.M., Cairo, M., Stevens, C.E., Rubinstein, P. and Kurtzberg, J. (2001), \u201cHematopoietic engraftment and survival in adult recipients of umbilical\u2010cord blood from unrelated donors\u201d, New England Journal of Medicine, Vol. 344 No. 24, pp. 1815\u201022."},{"key":"key2021010505160665800_b27","doi-asserted-by":"crossref","unstructured":"Leary, A.G., Ogawa, M., Strauss, L.C. and Civin, C.I. (1984), \u201cSingle cell origin of multilineage colonies in culture. Evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic processes\u201d, The Journal of Clinical Investigation, Vol. 74 No. 6, pp. 2193\u20107.","DOI":"10.1172\/JCI111645"},{"key":"key2021010505160665800_b29","doi-asserted-by":"crossref","unstructured":"Munzer, S.R. and Smith, F.O. (2001), \u201cLimited property rights umbilical cord blood\u201d, Journal of Pediatric Hematology\/Oncology, Vol. 23 No. 4, pp. 203\u20107.","DOI":"10.1097\/00043426-200105000-00004"},{"key":"key2021010505160665800_b30","doi-asserted-by":"crossref","unstructured":"Nakahata, T. and Ogawa, M. (1982), \u201cHemopoietic colony\u2010forming cells in umbilical cord blood with extensive capability to generate mono\u2010and multipotential hemopoietic progenitors\u201d, The Journal of Clinical Investigation, Vol. 70 No. 6, pp. 1324\u20108.","DOI":"10.1172\/JCI110734"},{"key":"key2021010505160665800_b31","unstructured":"Northeastern Reporter (1990), 2nd series, Illinois Supreme Court, pp. 1319\u201045."},{"key":"key2021010505160665800_b32","unstructured":"Pfeiffer (2000\/2001), \u201cBlood money\u201d, AIMS Journal, Vol. 12, pp. 1\u20103, available at: www.aims.org.uk (accessed 24 February 2003)."},{"key":"key2021010505160665800_b33","unstructured":"Rappa, M.A. and Debackere, K. (1992), \u201cTechnological communities and the diffusion of knowledge\u201d, R&D Management, Vol. 22, pp. 209\u201020."},{"key":"key2021010505160665800_b34","unstructured":"Regalado, A. (2002), \u201cBanking on umbilical cords\u201d, The Wall Street Journal, 24 April."},{"key":"key2021010505160665800_b35","doi-asserted-by":"crossref","unstructured":"Rocha, V., Wagner, J.E. Jr, Sobocinski, K.A., Klein, J.P., Zhang, M.J., Horowitz, M.M. and Gluckman, E. (2000), \u201cGraft\u2010versus\u2010host disease in children who have received a cord\u2010blood or bone marrow transplant from an HLA\u2010identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources\u201d, New England Journal of Medicine, Vol. 342 No. 25, pp. 1846\u201054.","DOI":"10.1056\/NEJM200006223422501"},{"key":"key2021010505160665800_b37","unstructured":"Rogers, E.M. (1982), The Diffusion of Innovations, Free Press, New York, NY."},{"key":"key2021010505160665800_b38","unstructured":"Rubinstein, P., Carrier, C., Scaradavou, A., Kurtzberg, J., Adamson, J., Migliaccio, A.R., Berkowitz, R.L., Cabbad, M., Dobrila, N.L., Taylor, P.E., Rosenfield, R.E. and Stevens, C.E. (1998), \u201cOutcomes among 562 recipients of placental\u2010blood transplants from unrelated donors\u201d, New England Journal of Medicine, Vol. 339 No. 22, pp. 1565\u201077."},{"key":"key2021010505160665800_b39","unstructured":"Rusinko, C.A. and Matthews, J.O. (1997), \u201cThe evolution of a technological community: the case of financial derivatives\u201d, Journal of Engineering and Technology Management, Vol. 14, pp. 315\u201036."},{"key":"key2021010505160665800_b40","unstructured":"Scientific Advisory Committee (2001), \u201cUmbilical cord blood banking\u201d, Opinion Paper 2, Royal College of Obstetricians and Gynaecologists, October."},{"key":"key2021010505160665800_b41","unstructured":"Subcommittee on Cord Blood Stem Cell Guidelines (1997), New York State Council on Human Blood and Transfusion Services Hematopoietic Progenitor Cell Committee, available at: www.wadsworth.org\/labcert\/blood."},{"key":"key2021010505160665800_b44","unstructured":"Van de Ven, A.H. (1993), \u201cA community perspective on the emergence of innovations\u201d, Journal of Engineering and Technology Management, Vol. 10, pp. 23\u201051."},{"key":"key2021010505160665800_b45","unstructured":"Van de Ven, A.H. (2002), \u201cInnovation scholarship and practice: the past, present and future\u201d, Technology and Innovation Management Distinguished Speaker at The Academy of Management National Meetings, Denver, CO, August 13."},{"key":"key2021010505160665800_b43","unstructured":"Van de Ven, A.H. and Angle, H.L. (1989), \u201cAn introduction to the Minnesota innovation research program\u201d, in Van de Ven, A.H., Angle, H.L. and Poole, M.S. (Eds), Research on the Management of Innovation, Harper & Row, New York, NY."},{"key":"key2021010505160665800_b46","unstructured":"Zaltman, G., Duncan, R. and Holbeck, J. (1973), Innovations and Organizations, Wiley, New York, NY."},{"key":"key2021010505160665800_b47","doi-asserted-by":"crossref","unstructured":"Zubair, A.C., Silberstein, L. and Ritz, J. (2002), \u201cAdult hematopoeitc stem cell plasticity\u201d, Transfusion, Vol. 42, pp. 1\u20108.","DOI":"10.1046\/j.1537-2995.2002.00156.x"},{"key":"key2021010505160665800_frd1","unstructured":"Broxmeyer, H.E. (1996), \u201cCord blood transplantation and biology\u201d, available at: http:\/\/haem.nus.edu.sg\/ishapd\/1996\/1996\/063.pdf (accessed 24 February 2003)."},{"key":"key2021010505160665800_frd2","unstructured":"Davis, J. (2002), \u201cCell and gene therapy regulatory requirements in the UK\u201d, International Society for Cellular Therapy Telegraft, Vol. 9, pp. 1\u20102."},{"key":"key2021010505160665800_frd3","unstructured":"Lecchi, L., Rebulla, P., Ratti, I., Magri, M., Garcea, F., Marangoni, F., Bertele, T., Giordano, R. and Sirchia, G. (2001), \u201cOutcomes of a program to evaluate mother and baby 6 months after umbilical cord blood donation\u201d, Transfusion, Vol. 41 No. 5, pp. 606\u201010."},{"key":"key2021010505160665800_frd4","doi-asserted-by":"crossref","unstructured":"Rocha, V., Cornish, J., Sievers, E.L., Filipovich, A., Locatelli, F., Peters, C., Remberger, M., Michel, G., Arcese, W., Dallorso, S., Tiedemann, K., Busca, A., Chan, K.W., Kato, S., Ortega, J., Vowels, M., Zander, A., Souillet, G., Oakill, A., Woolfrey, A., Pay, A.L., Green, A., Garnier, F., Ionescu, I., Wernet, P., Sirchia, G., Rubinstein, P., Chevret, S. and Gluckman, E. (2001), \u201cComparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia\u201d, Blood, Vol. 97 No. 10, pp. 2962\u201071.","DOI":"10.1182\/blood.V97.10.2962"},{"key":"key2021010505160665800_frd5","unstructured":"Sugarman, J.V., Kaalund, E., Kodish, M.F., Marshall, E.G., Reisner, B.S., Wilfond, P.R. and Wolpe (1997), \u201cConsensus statement: ethical issues in umbilical cord blood banking\u201d, Journal of the American Medical Association, Vol. 278 No. 11, pp. 938\u201043."},{"key":"key2021010505160665800_frd6","doi-asserted-by":"crossref","unstructured":"Zuck, T.F. (1996), \u201cThe applicability of cGMP to cord blood cell banking\u201d, Journal of Hematotherapy, Vol. 5, pp. 135\u20107.","DOI":"10.1089\/scd.1.1996.5.135"}],"container-title":["Journal of Health Organization and Management"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.emeraldinsight.com\/doi\/full-xml\/10.1108\/14777260310698748","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.emerald.com\/insight\/content\/doi\/10.1108\/14777260310698748\/full\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.emerald.com\/insight\/content\/doi\/10.1108\/14777260310698748\/full\/html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:19:56Z","timestamp":1753402796000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.emerald.com\/jhom\/article\/17\/6\/399-421\/213392"}},"subtitle":["The case of umbilical cord blood (UCB) banking"],"short-title":[],"issued":{"date-parts":[[2003,12,1]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12,1]]}},"alternative-id":["10.1108\/14777260310698748"],"URL":"https:\/\/doi.org\/10.1108\/14777260310698748","relation":{},"ISSN":["1477-7266"],"issn-type":[{"type":"print","value":"1477-7266"}],"subject":[],"published":{"date-parts":[[2003,12,1]]}}}